GLYC

Filed a patent for "polar cd33 ligands suitable for incorporation into carriers" on Wed, April 3, 2024

Filed a patent for "compounds and methods for reduction of cancer cell burden and protection of normal hematopoiesis" on Thu, June 1, 2023

Filed a patent for "compositions and methods for overcoming microenvironment-mediated resistance via e-selectin targeting" on Thu, July 13, 2023

Filed a patent for "e-selectin targeting agents" on Thu, November 16, 2023

Filed a patent for "methods of mobilizing marrow infiltrating lymphocytes and uses thereof" on Thu, December 28, 2023

Filed a patent for "methods for treating acute myeloid leukemia and related conditions" on Thu, December 28, 2023

Filed a patent for "highly potent multimeric e-selectin antagonists" on Thu, November 16, 2023

Filed a patent for "heterobifunctional inhibitors of e-selectin and galectin-3" on Thu, May 9, 2024

Filed a patent for "galectin-3 inhibiting c-glycosides" on Mon, November 13, 2023

Filed a patent for "galectin-3 inhibiting c-glycoside oximes" on Mon, November 20, 2023

Filed a patent for "compositions and methods for overcoming microenvironment-mediated resistance via e-selectin targeting" on Wed, January 24, 2024

Filed a patent for "galectin-3 inhibiting c-glycoside ketones, ethers, and alcohols" on Thu, March 23, 2023

Filed a patent for "treatment of acute respiratory distress syndrome and related conditions with antagonists of e-selectin" on Thu, May 11, 2023

Filed a patent for "cd33 ligands suitable for incorporation into carriers" on Thu, June 1, 2023

Filed a patent for "cd33 ligands suitable for incorporation into carriers" on Thu, June 1, 2023